1. Negative impact of zoledronic acid in R‐CHOP treated DLBCL with bone metastasis. (June 2017) Authors: Inoue, N.; Nishimura, N.; Takahashi, A.; Kusano, Y.; Yamauchi, H.; Ueda, K.; Mishima, Y.; Yokoyama, M.; Terui, Y.; Tsuyama, N.; Takeuchi, K.; Hatake, K. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 340 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PROGRESSION FREE SURVIVAL AT 12 MONTHS AFTER FIRST‐LINE THERAPY IS ASSOCIATED WITH FAVOURABLE OUTCOMES AFTER FIRST RELAPSE/PROGRESSION IN PERIPHERAL T‐CELL LYMPHOMA. (12th June 2019) Authors: Shirouchi, Y.; Yokoyama, M.; Fukuta, T.; Nishihara, A.; Inoue, N.; Uryu, H.; Kusano, Y.; Nishimura, N.; Mishima, Y.; Tsuyama, N.; Takeuchi, K.; Terui, Y. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 469 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Quantitative analysis of MYD88 L265P mutations by digital PCR is an independent prognostic factor for CNS relapse as well as systemic relapse and poor outcome. (June 2017) Authors: Nishimura, N.; Asaka, R.; Takeuchi, K.; Tsuyama, N.; Inoue, N.; Takahashi, A.; Yamauchi, H.; Kusano, Y.; Ueda, K.; Mishima, Y.; Yokoyama, M.; Terui, Y.; Hatake, K. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 277 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. THE RITUXIMAB MAINTENANCE THERAPY IMPROVES PROGNOSIS OF TRANSFORMED DIFFUSE LARGE B CELL LYMPHOMA. (12th June 2019) Authors: Uryu, H.; Mishima, Y.; Shirouchi, Y.; Fukuta, T.; Nishihara, A.; Inoue, N.; Kusano, Y.; Nishimura, N.; Yokoyama, M.; Tsuyama, N.; Takeuchi, K.; Terui, Y. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 430 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗